Suppr超能文献

干预方案:优化治疗以预防多病老年患者的非必要住院(OPERAM):使用计算机决策支持系统支持的结构化药物治疗审查。

Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system.

机构信息

Pharmaceutical Care Research Group. School of Pharmacy, Cavanagh Pharmacy Building, University College Cork, Cork, Ireland.

Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

出版信息

BMC Health Serv Res. 2020 Mar 17;20(1):220. doi: 10.1186/s12913-020-5056-3.

Abstract

BACKGROUND

Several approaches to medication optimisation by identifying drug-related problems in older people have been described. Although some interventions have shown reductions in drug-related problems (DRPs), evidence supporting the effectiveness of medication reviews on clinical and economic outcomes is lacking. Application of the STOPP/START (version 2) explicit screening tool for inappropriate prescribing has decreased inappropriate prescribing and significantly reduced adverse drug reactions (ADRs) and associated healthcare costs in older patients with multi-morbidity and polypharmacy. Therefore, application of STOPP/START criteria during a medication review is likely to be beneficial. Incorporation of explicit screening tools into clinical decision support systems (CDSS) has gained traction as a means to improve both quality and efficiency in the rather time-consuming medication review process. Although CDSS can generate more potential inappropriate medication recommendations, some of these have been shown to be less clinically relevant, resulting in alert fatigue. Moreover, explicit tools such as STOPP/START do not cover all relevant DRPs on an individual patient level. The OPERAM study aims to assess the impact of a structured drug review on the quality of pharmacotherapy in older people with multi-morbidity and polypharmacy. The aim of this paper is to describe the structured, multi-component intervention of the OPERAM trial and compare it with the approach in the comparator arm.

METHOD

This paper describes a multi-component intervention, integrating interventions that have demonstrated effectiveness in defining DRPs. The intervention involves a structured history-taking of medication (SHiM), a medication review according to the systemic tool to reduce inappropriate prescribing (STRIP) method, assisted by a clinical decision support system (STRIP Assistant, STRIPA) with integrated STOPP/START criteria (version 2), followed by shared decision-making with both patient and attending physician. The developed method integrates patient input, patient data, involvement from other healthcare professionals and CDSS-assistance into one structured intervention.

DISCUSSION

The clinical and economical effectiveness of this experimental intervention will be evaluated in a cohort of hospitalised, older patients with multi-morbidity and polypharmacy in the multicentre, randomized controlled OPERAM trial (OPtimising thERapy to prevent Avoidable hospital admissions in the Multi-morbid elderly), which will be completed in the last quarter of 2019.

TRIAL REGISTRATION

Universal Trial Number: U1111-1181-9400 Clinicaltrials.gov: NCT02986425, Registered 08 December 2016. FOPH (Swiss national portal): SNCTP000002183. Netherlands Trial Register: NTR6012 (07-10-2016).

摘要

背景

已经描述了几种通过识别老年人的药物相关问题来优化药物治疗的方法。尽管一些干预措施已经显示出减少药物相关问题(DRP)的效果,但缺乏药物审查对临床和经济结果有效性的证据。应用 STOPP/START(版本 2)明确的不适当处方筛选工具减少了不适当处方,并显著降低了患有多种合并症和多种药物的老年患者的药物不良反应(ADR)和相关医疗保健费用。因此,在药物审查期间应用 STOPP/START 标准可能是有益的。将明确的筛选工具纳入临床决策支持系统(CDSS)已成为提高药物审查过程的质量和效率的一种手段。尽管 CDSS 可以生成更多潜在的不适当药物建议,但其中一些建议的临床相关性较低,导致警报疲劳。此外,像 STOPP/START 这样的明确工具并不能涵盖个体患者水平上的所有相关 DRP。OPERAM 研究旨在评估结构化药物审查对患有多种合并症和多种药物的老年人药物治疗质量的影响。本文的目的是描述 OPERAM 试验的结构化、多组件干预措施,并将其与对照组的方法进行比较。

方法

本文描述了一种多组件干预措施,该措施整合了已证明可有效确定 DRP 的干预措施。该干预措施包括药物史的结构化采集(SHiM)、根据系统性减少不适当处方的工具(STRIP)方法进行药物审查,辅助以具有集成 STOPP/START 标准(版本 2)的临床决策支持系统(STRIP Assistant,STRIPA),然后与患者和主治医生共同做出决策。所开发的方法将患者输入、患者数据、其他医疗保健专业人员的参与和 CDSS 辅助整合到一个结构化的干预措施中。

讨论

这项实验性干预措施的临床和经济效果将在多中心、随机对照的 OPERAM 试验(优化治疗以预防多病老年患者的可避免住院)的一组患有多种合并症和多种药物的住院老年患者中进行评估,该试验将于 2019 年最后一个季度完成。

试验注册

通用试验编号:U1111-1181-9400 Clinicaltrials.gov:NCT02986425,注册于 2016 年 12 月 8 日。FOPH(瑞士国家门户):SNCTP000002183。荷兰试验登记册:NTR6012(2016 年 10 月 7 日)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/7076919/b5f440296130/12913_2020_5056_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验